211 related articles for article (PubMed ID: 22343514)
1. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis.
Poynard T; Lenaour G; Vaillant JC; Capron F; Munteanu M; Eyraud D; Ngo Y; M'Kada H; Ratziu V; Hannoun L; Charlotte F
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):657-63.e7. PubMed ID: 22343514
[TBL] [Abstract][Full Text] [Related]
2. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
Poynard T; Halfon P; Castera L; Charlotte F; Le Bail B; Munteanu M; Messous D; Ratziu V; Benhamou Y; Bourlière M; De Ledinghen V;
Aliment Pharmacol Ther; 2007 Mar; 25(6):733-9. PubMed ID: 17311607
[TBL] [Abstract][Full Text] [Related]
3. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
[TBL] [Abstract][Full Text] [Related]
4. FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate.
Poynard T; de Ledinghen V; Zarski JP; Stanciu C; Munteanu M; Vergniol J; France J; Trifan A; Moussalli J; Lebray P; Thabut D; Ratziu V
Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):720-30. PubMed ID: 21852224
[TBL] [Abstract][Full Text] [Related]
5. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
[TBL] [Abstract][Full Text] [Related]
6. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
Nguyen-Khac E; Chatelain D; Tramier B; Decrombecque C; Robert B; Joly JP; Brevet M; Grignon P; Lion S; Le Page L; Dupas JL
Aliment Pharmacol Ther; 2008 Nov; 28(10):1188-98. PubMed ID: 18705692
[TBL] [Abstract][Full Text] [Related]
7. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.
Sebastiani G; Castera L; Halfon P; Pol S; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
Aliment Pharmacol Ther; 2011 Nov; 34(10):1202-16. PubMed ID: 21981787
[TBL] [Abstract][Full Text] [Related]
8. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
Sebastiani G; Vario A; Guido M; Alberti A
J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.
Tural C; Tor J; Sanvisens A; Pérez-Alvarez N; Martínez E; Ojanguren I; García-Samaniego J; Rockstroh J; Barluenga E; Muga R; Planas R; Sirera G; Rey-Joly C; Clotet B
Clin Gastroenterol Hepatol; 2009 Mar; 7(3):339-45. PubMed ID: 19171202
[TBL] [Abstract][Full Text] [Related]
11. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.
Halfon P; Bacq Y; De Muret A; Penaranda G; Bourliere M; Ouzan D; Tran A; Botta D; Renou C; Bréchot MC; Degott C; Paradis V
J Hepatol; 2007 Mar; 46(3):395-402. PubMed ID: 17156890
[TBL] [Abstract][Full Text] [Related]
12. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation.
Cross TJ; Calvaruso V; Foxton MR; Manousou P; Quaglia A; Grillo F; Dhillon AP; Nolan J; Chang TP; O'Grady J; Heneghan MA; O'Beirne JP; Burroughs AK; Harrison PM
J Viral Hepat; 2010 Sep; 17(9):640-9. PubMed ID: 19922441
[TBL] [Abstract][Full Text] [Related]
13. Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C.
Poynard T; de Ledinghen V; Zarski JP; Stanciu C; Munteanu M; Vergniol J; France J; Trifan A; Lenaour G; Vaillant JC; Ratziu V; Charlotte F;
Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):455-63. PubMed ID: 22959098
[TBL] [Abstract][Full Text] [Related]
14. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
[TBL] [Abstract][Full Text] [Related]
15. FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
Halfon P; Munteanu M; Poynard T
Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):22-39. PubMed ID: 18973844
[TBL] [Abstract][Full Text] [Related]
16. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.
Boursier J; de Ledinghen V; Zarski JP; Rousselet MC; Sturm N; Foucher J; Leroy V; Fouchard-Hubert I; Bertrais S; Gallois Y; Oberti F; Dib N; Calès P
Am J Gastroenterol; 2011 Jul; 106(7):1255-63. PubMed ID: 21468012
[TBL] [Abstract][Full Text] [Related]
17. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.
Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Saxena R; Aisen AM
AJR Am J Roentgenol; 2009 Dec; 193(6):1556-60. PubMed ID: 19933647
[TBL] [Abstract][Full Text] [Related]
18. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.
Calès P; Halfon P; Batisse D; Carrat F; Perré P; Penaranda G; Guyader D; d'Alteroche L; Fouchard-Hubert I; Michelet C; Veillon P; Lambert J; Weiss L; Salmon D; Cacoub P
J Hepatol; 2010 Aug; 53(2):238-44. PubMed ID: 20493576
[TBL] [Abstract][Full Text] [Related]
19. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients.
Bottero J; Lacombe K; Guéchot J; Serfaty L; Miailhes P; Bonnard P; Wendum D; Molina JM; Lascoux-Combe C; Girard PM
J Hepatol; 2009 Jun; 50(6):1074-83. PubMed ID: 19398234
[TBL] [Abstract][Full Text] [Related]
20. Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.
Rizzo L; Calvaruso V; Cacopardo B; Alessi N; Attanasio M; Petta S; Fatuzzo F; Montineri A; Mazzola A; L'abbate L; Nunnari G; Bronte F; Di Marco V; Craxì A; Cammà C
Am J Gastroenterol; 2011 Dec; 106(12):2112-20. PubMed ID: 21971536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
